Early cognitive stimulation compensates for memory and pathological changes in Tg2576 mice

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 6, 2013, Pages 837-847

  Gerenu, Gorka ^a   Dobarro, Marta ^a   Ramirez, Maria J ^a,b   Gil Bea, Francisco J ^b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Amyloid; Cognitive training; HAPP transgenic mouse; Synaptic; Tau

Indexed keywords

BETA CATENIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; MEMORY; MOUSE; NONHUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROBLEM SOLVING; SOCIAL BEHAVIOR; SPATIAL MEMORY; SYNAPSE; WILD TYPE;

ADAM PROTEINS; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ANTIGENS, CD; ASPARTIC ACID ENDOPEPTIDASES; BEHAVIOR, ANIMAL; BIOLOGICAL MARKERS; CARRIER PROTEINS; COGNITION; DISEASE MODELS, ANIMAL; FEMALE; GUANYLATE KINASE; HIPPOCAMPUS; HUMANS; IMMUNOGLOBULINS; MAZE LEARNING; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 84876263228     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.02.018     Document Type: Article

References (43)

1. Stern Y. Cognitive reserve and Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2006, 20:S69-S74.
2. Koepsell T.D., Kurland B.F., Harel O., Johnson E.A., Zhou X.H., Kukull W.A. Education, cognitive function, and severity of neuropathology in Alzheimer disease. Neurology 2008, 70:1732-1739.
3. Andel R., Vigen C., Mack W.J., Clark L.J., Gatz M. The effect of education and occupational complexity on rate of cognitive decline in Alzheimer's patients. J. Int. Neuropsychol. Soc. 2006, 12:147-152.
4. Carlson M.C., Helms M.J., Steffens D.C., Burke J.R., Potter G.G., Plassman B.L. Midlife activity predicts risk of dementia in older male twin pairs. Alzheimers Dement 2008, 4:324-331.
5. Verghese J., Lipton R.B., Katz M.J., Hall C.B., Derby C.A., Kuslansky G., Ambrose A.F., Sliwinski M., Buschke H. Leisure activities and the risk of dementia in the elderly. N. Engl. J. Med. 2003, 348:2508-2516.
6. Rovio S., Kareholt I., Helkala E.L., Viitanen M., Winblad B., Tuomilehto J., Soininen H., Nissinen A., Kivipelto M. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol. 2005, 4:705-711.
7. Owen A.M., Hampshire A., Grahn J.A., Stenton R., Dajani S., Burns A.S., Howard R.J., Ballard C.G. Putting brain training to the test. Nature 2010, 465:775-778.
8. Jankowsky J.L., Melnikova T., Fadale D.J., Xu G.M., Slunt H.H., Gonzales V., Younkin L.H., Younkin S.G., Borchelt D.R., Savonenko A.V. Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease. J. Neurosci. 2005, 25:5217-5224.
9. Wolf S.A., Kronenberg G., Lehmann K., Blankenship A., Overall R., Staufenbiel M., Kempermann G. Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer's disease. Biol. Psychiatry 2006, 60:1314-1323.
10. Costa D.A., Cracchiolo J.R., Bachstetter A.D., Hughes T.F., Bales K.R., Paul S.M., Mervis R.F., Arendash G.W., Potter H. Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms. Neurobiol. Aging 2007, 28:831-844.
11. Gortz N., Lewejohann L., Tomm M., Ambree O., Keyvani K., Paulus W., Sachser N. Effects of environmental enrichment on exploration, anxiety, and memory in female TgCRND8 Alzheimer mice. Behav. Brain Res. 2008, 191:43-48.
12. Cotel M.C., Jawhar S., Christensen D.Z., Bayer T.A., Wirths O. Environmental enrichment fails to rescue working memory deficits, neuron loss, and neurogenesis in APP/PS1KI mice. Neurobiol. Aging 2010, 33:96-107.
13. Jankowsky J.L., Xu G., Fromholt D., Gonzales V., Borchelt D.R. Environmental enrichment exacerbates amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J. Neuropathol. Exp. Neurol. 2003, 62:1220-1227.
14. Lazarov O., Robinson J., Tang Y.P., Hairston I.S., Korade-Mirnics Z., Lee V.M., Hersh L.B., Sapolsky R.M., Mirnics K., Sisodia S.S. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 2005, 120:701-713.
15. Arendash G.W., Garcia M.F., Costa D.A., Cracchiolo J.R., Wefes I.M., Potter H. Environmental enrichment improves cognition in aged Alzheimer's transgenic mice despite stable beta-amyloid deposition. Neuroreport 2004, 15:1751-1754.
16. Nithianantharajah J., Hannan A.J. Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat. Rev. Neurosci. 2006, 7:697-709.
17. Cracchiolo J.R., Mori T., Nazian S.J., Tan J., Potter H., Arendash G.W. Enhanced cognitive activity - over and above social or physical activity - is required to protect Alzheimer's mice against cognitive impairment, reduce Abeta deposition, and increase synaptic immunoreactivity. Neurobiol. Learn. Mem. 2007, 88:277-294.
18. Mirochnic S., Wolf S., Staufenbiel M., Kempermann G. Age effects on the regulation of adult hippocampal neurogenesis by physical activity and environmental enrichment in the APP23 mouse model of Alzheimer disease. Hippocampus 2009, 19:1008-1018.
19. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 1996, 274:99-102.
20. Aisa B., Tordera R., Lasheras B., Del Rio J., Ramirez M.J. Cognitive impairment associated to HPA axis hyperactivity after maternal separation in rats. Psychoneuroendocrinology 2007, 32:256-266.
21. Cuadrado-Tejedor M., Hervias I., Ricobaraza A., Puerta E., Perez-Roldan J.M., Garcia-Barroso C., Franco R., Aguirre N., Garcia-Osta A. Sildenafil restores cognitive function without affecting beta-amyloid burden in a mouse model of Alzheimer's disease. Br. J. Pharmacol. 2011, 164:2029-2041.
22. Puzzo D., Privitera L., Fa M., Staniszewski A., Hashimoto G., Aziz F., Sakurai M., Ribe E.M., Troy C.M., Mercken M., Jung S.S., Palmeri A., Arancio O. Endogenous amyloid-beta is necessary for hippocampal synaptic plasticity and memory. Ann. Neurol. 2011, 69:819-830.
23. Mouri A., Noda Y., Hara H., Mizoguchi H., Tabira T., Nabeshima T. Oral vaccination with a viral vector containing Abeta cDNA attenuates age-related Abeta accumulation and memory deficits without causing inflammation in a mouse Alzheimer model. FASEB J. 2007, 21:2135-2148.
24. Morgan D., Diamond D.M., Gottschall P.E., Ugen K.E., Dickey C., Hardy J., Duff K., Jantzen P., DiCarlo G., Wilcock D., Connor K., Hatcher J., Hope C., Gordon M., Arendash G.W. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 2000, 408:982-985.
25. Westerman M.A., Cooper-Blacketer D., Mariash A., Kotilinek L., Kawarabayashi T., Younkin L.H., Carlson G.A., Younkin S.G., Ashe K.H. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J. Neurosci. 2002, 22:1858-1867.
26. Taglialatela G., Hogan D., Zhang W.R., Dineley K.T. Intermediate- and long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibition. Behav. Brain Res. 2009, 200:95-99.
27. Neves G., Cooke S.F., Bliss T.V. Synaptic plasticity, memory and the hippocampus: a neural network approach to causality. Nat. Rev. Neurosci. 2008, 9:65-75.
28. Larson M.E., Lesne S.E. Soluble Abeta oligomer production and toxicity. J. Neurochem. 2012, 120(Suppl. 1):125-139.
29. Tomidokoro Y., Ishiguro K., Harigaya Y., Matsubara E., Ikeda M., Park J.M., Yasutake K., Kawarabayashi T., Okamoto K., Shoji M. Abeta amyloidosis induces the initial stage of tau accumulation in APP(Sw) mice. Neurosci. Lett. 2001, 299:169-172.
30. Patrick G.N., Zukerberg L., Nikolic M., de la Monte S., Dikkes P., Tsai L.H. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 1999, 402:615-622.
31. L. Verret, A. Krezymon, H. Halley, S. Trouche, M. Zerwas, M. Lazouret, J.M. Lassalle, C. Rampon, Transient enriched housing before amyloidosis onset sustains cognitive improvement in Tg2576 mice, Neurobiol. Aging (in press).
32. Verbitsky M., Yonan A.L., Malleret G., Kandel E.R., Gilliam T.C., Pavlidis P. Altered hippocampal transcript profile accompanies an age-related spatial memory deficit in mice. Learn. Mem. 2004, 11:253-260.
33. Chen G., Chen K.S., Knox J., Inglis J., Bernard A., Martin S.J., Justice A., McConlogue L., Games D., Freedman S.B., Morris R.G. A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature 2000, 408:975-979.
34. Morgan D. Learning and memory deficits in APP transgenic mouse models of amyloid deposition. Neurochem. Res. 2003, 28:1029-1034.
35. Lesne S., Koh M.T., Kotilinek L., Kayed R., Glabe C.G., Yang A., Gallagher M., Ashe K.H. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 2006, 440:352-357.
36. Cheng I.H., Scearce-Levie K., Legleiter J., Palop J.J., Gerstein H., Bien-Ly N., Puolivali J., Lesne S., Ashe K.H., Muchowski P.J., Mucke L. Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. J. Biol. Chem. 2007, 282:23818-23828.
37. Billings L.M., Green K.N., McGaugh J.L., LaFerla F.M. Learning decreases A beta*56 and tau pathology and ameliorates behavioral decline in 3xTg-AD mice. J. Neurosci. 2007, 27:751-761.
38. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003, 300:486-489.
39. Ferrer I., Gomez-Isla T., Puig B., Freixes M., Ribe E., Dalfo E., Avila J. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies. Curr. Alzheimer Res. 2005, 2:3-18.
40. Otth C., Concha I.I., Arendt T., Stieler J., Schliebs R., Gonzalez-Billault C., Maccioni R.B. AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576. J. Alzheimers Dis. 2002, 4:417-430.
41. Hurtado D.E., Molina-Porcel L., Iba M., Aboagye A.K., Paul S.M., Trojanowski J.Q., Lee V.M. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model. Am. J. Pathol. 2010, 177:1977-1988.
42. Jin M., Shepardson N., Yang T., Chen G., Walsh D., Selkoe D.J. Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:5819-5824.
43. Hu Y.S., Xu P., Pigino G., Brady S.T., Larson J., Lazarov O. Complex environment experience rescues impaired neurogenesis, enhances synaptic plasticity, and attenuates neuropathology in familial Alzheimer's disease-linked APPswe/PS1DeltaE9 mice. FASEB J. 2010, 24:1667-1681.